Venture Profile

Nepipen

Seyeon Park (EE '25) and Joshua Ashvil (ME '25), are creating a two-dose epinephrine autoinjector that features a more intuitive design than the existing design which has often involved user error.

Grant Year2025

FoundersStudent Team

MentorsMatched

StatusIn Development

The Venture

Seyeon Park (EE '25) and Joshua Ashvil (ME '25) are creating a more intuitive two-dose epinephrine autoinjector designed to reduce common user errors.

Milestones

Prototype / proof of concept
Testing and validation
Mentor review
Next-stage goals

Executive Summary

A concise downloadable document for reviewers, partners, donors, and media.

View Summary